Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2024-11-26 06:03 am Purchase | 13D | CalciMedica Inc. CALC | Sanderling Venture Partners VI LP | 2,550,550 18.300% | 2,550,550 (New Position) | View |
2024-11-14 3:32 pm Purchase | 13G | CalciMedica Inc. CALC | Soleus Private Equity Fund III L.P. | 1,175,856 8.500% | 1,175,856 (New Position) | View |
2024-11-14 1:05 pm Sale | 13G | CalciMedica Inc. CALC | LYTTON LAURENCE W | 468,943 4.400% | -287,237 (-37.99%) | View |
2024-11-13 5:32 pm Sale | 13G | CalciMedica Inc. CALC | Stonepine Capital Management LLC | 0 0.000% | -1,045,204 (Position Closed) | View |
2024-11-06 4:17 pm Purchase | 13D | CalciMedica Inc. CALC | Valence Investments SPV VI LLC | 1,217,678 9.000% | 54,368 (+4.67%) | View |
2024-07-08 12:48 pm Purchase | 13G | CalciMedica Inc. CALC | LYTTON LAURENCE W | 756,180 6.900% | 756,180 (New Position) | View |
2024-02-08 5:55 pm Purchase | 13D | CalciMedica Inc. CALC | Valence Investments SPV VI LLC | 1,163,310 11.000% | 194,386 (+20.06%) | View |
2024-02-08 10:08 am Purchase | 13G | CalciMedica Inc. CALC | Soleus Capital Master Fund L.P. | 1,105,016 9.990% | 321,112 (+40.96%) | View |
2024-02-07 11:14 am Purchase | 13G | CalciMedica Inc. CALC | BML Investment Partners L.P. | 220,424 2.100% | 220,424 (New Position) | View |
2024-02-05 4:48 pm Unchanged | 13D | CalciMedica Inc. CALC | ORBIMED ADVISORS LLC | 297,380 2.900% | 0 (Unchanged) | View |
2024-02-01 5:29 pm Purchase | 13G | CalciMedica Inc. CALC | Flynn James E | 2,613,012 9.990% | 2,336,214 (+844.01%) | View |
2024-02-01 4:15 pm Purchase | 13G | CalciMedica Inc. CALC | Aisling Capital V LP | 1,042,228 5.100% | 1,042,228 (New Position) | View |
2024-01-31 4:27 pm Purchase | 13G | CalciMedica Inc. CALC | Stonepine Capital Management LLC | 1,045,204 9.700% | 1,045,204 (New Position) | View |
2024-01-26 4:15 pm Purchase | 13G | CalciMedica Inc. CALC | Soleus Capital Master Fund L.P. | 783,904 7.400% | 783,904 (New Position) | View |
2023-11-22 4:31 pm Purchase | 13D | CalciMedica Inc. CALC | Valence Investments SPV VI LLC | 968,924 16.400% | 45,946 (+4.98%) | View |
2023-05-23 5:25 pm Sale | 13D | CalciMedica Inc. CALC | Flynn James E | 276,798 4.890% | -100,466 (-26.63%) | View |
2023-03-30 5:30 pm Purchase | 13D | CalciMedica Inc. CALC | Valence Investments SPV VI LLC | 922,978 16.600% | 922,978 (New Position) | View |
2023-03-30 4:01 pm Purchase | 13G | CalciMedica Inc. CALC | REVELATION HEALTHCARE FUND I L.P. | 542,029 9.800% | 542,029 (New Position) | View |
2023-03-28 09:37 am Sale | 13D | CalciMedica Inc. CALC | Flynn James E | 377,264 6.840% | -1,336,609 (-77.99%) | View |
2023-03-27 4:09 pm Purchase | 13D | CalciMedica Inc. CALC | Flynn James E | 1,713,873 24.490% | 1,713,873 (New Position) | View |